Skip to content
Find an ETF
← All ETFs

Available in 10 markets

Amundi FTSE MIB Daily (-2x) Inverse UCITS ETF Acc

Amundi · FR0010446666

Amundi FTSE MIB Daily (-2x) Inverse UCITS ETF Acc is an exchange-traded fund (ETF) from Amundi, traded under the ticker XBRMI (ISIN FR0010446666). It lets you buy a basket of holdings in a single trade, spreading your money across them rather than one company. At its core it is a focused, thematic fund: it concentrates on the financials part of…

· Tracks the FTSE MIB Super Short Strategy RT Gross TR Index index ?
Equity ?Accumulating ?Synthetic ?France ?
Higher feeReinvests dividendsUses a swapOtherConcentrated in a few names
Fund size (AUM) ?
€37.9M
Risk level (SRI) ?
5 / 7 · High
1-year return ?
-32.5%
Total return · to 2026-10-09
Yearly fee (TER) ?
0.60%
All-in cost ≈ 0.60%

About this fund

What you own

The FTSE MIB Super Short Strategy RT Gross TR Index index is the benchmark this fund aims to copy. By holding it, this fund gives you a stake in around 10 companies across Other in a single purchase.

Dividends

The fund automatically reinvests dividends back into itself, so your holding grows without cash payouts.

Read more

Rolling the dividends straight back in means your money compounds automatically, with nothing for you to reinvest by hand. The flip side is there is no cash income; the growth simply shows up as a higher fund value. Note that reinvested dividends can still be taxable in some countries even though you never receive the cash — the rules depend on where you live.

How it works

The fund uses a swap contract with a bank to mirror the index, instead of holding the shares directly.

Read more

Rather than hold the shares, the fund signs a swap with a bank that agrees to pay it the index return. This can track some markets very tightly and cheaply, but it adds counterparty risk — the small chance the swap partner cannot pay — which regulated funds limit and back with collateral. It reaches the same index a different way, with a different set of trade-offs to physical funds.

Cost

0.60%Yearly fee (TER)
0.60%All-in cost

The yearly running cost of the fund, shown as a % of your money. Lower is cheaper.

Read more

For example, a 0.20% fee works out at €0.20 a year for every €100 invested — that’s a generic illustration of the mechanic, not this fund’s own fee. It is skimmed quietly from inside the fund a little each day, so you never get a bill — but it drags on your return every year you hold. On a broad index ETF it is usually a small fraction of a percent; the gap between a cheap and a pricey fund looks tiny on day one but compounds over decades, which is why it is worth a glance.

Fund facts

Index tracked ?
FTSE MIB Super Short Strategy RT Gross TR Index
Replication ?
Synthetic
Uses a swap contract
Regulation ?
UCITS
Yes
Launched
Sep 2018
8-year track record
Recommended holding period
1 day

Performance

89.092.596.099.5103202520252025

Growth of €100 invested — both lines start at €100.

Amundi FTSE MIB Daily (-2x) Inverse UCITS ETF Acc Average FTSE MIB Super Short Strategy RT Gross TR Index ETF (funds we track) ?

Compared with the average fund tracking the same index — our own data, not the licensed index itself.

YTD-24.1%
1 year-32.5%
3 years-36.9%
5 years-32.5%

Return, year by year

+0.0
-43.9
-25.4
-49.0
'22'23'24'25
1 of 4 up yearsBest: 2022 +0.0%Worst: 2025 -49.0%Calendar-year total returns, in EUR

How bumpy has it been?

31.7%
Volatility (1y) ?
How much the price swings year to year — lower is calmer.
-80.1%
Worst drop (3y) ?
The biggest fall from a peak over the last three years.
-1.17
Return for the risk (3y) ?
Reward earned per unit of bumpiness.

The bigger picture

-87.4%
Since inception
Total growth since launch — about -32.5% a year.
+17.8%
Best 12 months
The strongest one-year stretch on record.
-57.1%
Worst 12 months
The weakest one-year stretch on record.
-90.3%
Worst fall on record ?
It has not fully recovered yet.

What's inside

By sector ?

Financials50.5%
Utilities14.7%
Consumer Discretionary9.7%
Industrials8.7%
Energy8.5%
Technology5.4%
Health Care1.1%
Consumer Staples0.5%

The 10 biggest holdings make up 72.1% of the fund.

Top 10 holdings

#CompanyWeight
1UNICREDIT SPA14.4%
2INTESA SANPAOLO13.8%
3ENEL SPA9.6%
4ENI SPA MILAN6.5%
5FERRARI NV MILAN5.9%
6GENERALI MILAN5.8%
7PRYSMIAN SPA5.3%
8STMICROELECTRONICS/MILAN4.6%
9BANCA MONTE DEI PASCHI SIENA REGR3.2%
10BPER BANCA SPA3.0%

Where to buy this fund

Set from your language & location — change it if it's wrong.

Where it trades

ExchangeTickerCurrency
EOXBRMIEUR★ Primary
EUR listings
B2XBRMIBEUR
B3XBRMIMEUR
B4XBRMIBEUR
Borsa ItalianaXBRMIBEUR
BQXBRMIMEUR
E1XBRMIEUR
EBXBRMIMEUR
EPXBRMIBEUR
Euronext ParisXBRMIEUR
EZXBRMIBEUR
I2XBRMIMEUR
ICXBRMIBEUR
IXXBRMIMEUR
L1XBRMIMEUR
L3XBRMIMEUR
LO0WA5EUR
POXBRMIMEUR
QEXBRMIMEUR
QXXBRMIMEUR
S1XBRMIMEUR
S4XBRMIMEUR
T1XBRMIMEUR
T2XBRMIBEUR
TQXBRMIMEUR
WTXBRMIBEUR
X1XBRMIEUR
X2XBRMIEUR
X9XBRMIBEUR
XCXBRMIEUR
XEXBRMIEUR
XLXBRMIEUR
XVXBRMIEUR
XWXBRMIEUR
XXXBRMIEUR
For serious comparison — full data holdings, percentiles, advanced risk, tilt, flows

How it ranks vs peers

🪙 Cheaper than 18% of similar ETFs💰 All-in cost cheaper than 27%📈 Higher 1-yr return than 4%📈 Higher 3-yr return than 2%📈 Higher 5-yr return than 2%📊 Behind its category by 39.1% (1-yr) (category average +6.5%)📊 Behind its category by 44.3% (3-yr) (category average +7.4%)📊 Behind its category by 36.4% (5-yr) (category average +3.9%)

Versus the Equity (stocks) · Other · EUR ETFs we track.

Advanced risk

-1.66
Sortino (3y) ?
-0.46
Calmar (3y) ?
23.4%
Downside deviation ?
25%
Up months (hit rate) ?
€0.25
52-week high ?
€0.14
52-week low ?

Tilt vs a world tracker

Italy+99.2
United States-72.1
Financials+34.2
Technology-23.8
Utilities+12.2
Health Care-8.3

Percentage points over / under a broad world-equity tracker (not a licensed benchmark).

Estimated fund flows

−€600,000
Estimated net flow, last 3 months

Estimated from fund-size changes.

Similar funds

We found 6 funds that do much the same job as this one. To pick them we matched this fund's asset class and region, then show how close each match is below.

Matched on🌍 Other stocks
Compare side by side
6 similar funds
Amundi FTSE MIB Daily (-2x) Inverse UCITS ETF AccAmundiYou're viewingState Street® Technology Select Sector SPDR® ETFSPDRBroader matchSchwab International Equity ETFSchwabBroader matchState Street® Financial Select Sector SPDR® ETFSPDRBroader matchState Street® Health Care Select Sector SPDR® ETFSPDRBroader matchState Street® Energy Select Sector SPDR® ETFSPDRBroader matchState Street® Industrial Select Sector SPDR® ETFSPDRBroader match
Why it's similarThis is the fund on this page.
StocksCheaper fee
Tracks a different index in the same category.
StocksCheaper fee
Tracks a different index in the same category.
StocksCheaper fee
Tracks a different index in the same category.
StocksCheaper fee
Tracks a different index in the same category.
StocksCheaper fee
Tracks a different index in the same category.
StocksCheaper fee
Tracks a different index in the same category.
Index trackedFTSE MIB Super Short Strategy RT Gross TR IndexTechnology Select Sector IndexFTSE Developed ex US IndexFinancial Select Sector IndexHealth Care Select Sector IndexEnergy Select Sector IndexIndustrial Select Sector Index
Yearly fee (TER)0.60%0.08%0.03%0.08%0.08%0.08%0.08%
All-in cost0.60%0.00%0.00%0.00%0.00%0.00%0.00%
Fund size€37.9M€115.1B€58.5B€44.8B€38.5B€36.5B€28.1B
DomicileFranceUnited StatesUnited StatesUnited StatesUnited StatesUnited StatesUnited States
ReplicationSynthetic (swap)Physical (full)Physical (full)Physical (full)Physical (full)Physical (full)Physical (full)
3-yr return p.a.-36.9%+34.9%+13.9%+17.8%+8.7%+13.9%+18.5%
5-yr return p.a.-32.5%+21.4%+6.7%+6.8%+5.5%+17.5%+10.7%
# holdings10771,49480632486

The fund on this page stays pinned on the left — scroll or use ‹ › to compare it against each one.

Open the full comparison tool →
Data as of 2026-10-09 · Source: issuer data, compiled by Finance Hamster

New to ETFs? Start with the basics →

Finance Hamster provides educational information about ETFs and investing. It is not investment, tax, or legal advice, and not a recommendation to buy or sell any security. Markets carry risk; do your own research or consult a licensed adviser.